Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma.

El Hajj II, Lawrence KA, Tirkes T, Shahda S, Sherman S.

Clin Case Rep. 2018 May 8;6(7):1368-1370. doi: 10.1002/ccr3.1571. eCollection 2018 Jul.

2.

Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.

Kays JK, Shahda S, Stanley M, Bell TM, O'Neill BH, Kohli MD, Couch ME, Koniaris LG, Zimmers TA.

J Cachexia Sarcopenia Muscle. 2018 Jul 5. doi: 10.1002/jcsm.12307. [Epub ahead of print]

3.

Two Months of Therapy: A Case of Pathologic Complete Response to Chemoimmunotherapy in a Patient With Metastatic Colorectal Cancer.

Armstrong S, Al-Ghawi H, Helft P, House MG, Spittler AJ, Wu HH, Shahda S.

Clin Colorectal Cancer. 2018 Jun;17(2):e229-e232. doi: 10.1016/j.clcc.2017.12.006. Epub 2017 Dec 13. No abstract available.

PMID:
29311032
4.

Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.

Dadi N, Stanley M, Shahda S, O'Neil BH, Sehdev A.

Anticancer Res. 2017 Oct;37(10):5533-5539. Review.

PMID:
28982867
5.

Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.

Hashemi-Sadraei N, Gbolahan OB, Salfity H, O'Neil B, House MG, Shahda S.

Am J Clin Oncol. 2017 Sep 29. doi: 10.1097/COC.0000000000000409. [Epub ahead of print]

PMID:
28968257
6.

Energy drink consumption is associated with reduced sleep quality among college students: a cross-sectional study.

Faris MAE, Jahrami H, Al-Hilali MM, Chehyber NJ, Ali SO, Shahda SD, Obaid RS.

Nutr Diet. 2017 Jul;74(3):268-274. doi: 10.1111/1747-0080.12289. Epub 2016 Jun 9.

PMID:
28731611
7.

Myeloid sarcoma of the sigmoid colon: An unusual presentation of a rare condition.

El Hajj II, Easler JJ, Ceppa EP, Shahda S.

Dig Liver Dis. 2017 Nov;49(11):1280. doi: 10.1016/j.dld.2017.05.012. Epub 2017 May 24. No abstract available.

PMID:
28606757
8.

Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers.

Mosher CE, Secinti E, Johns SA, O'Neil BH, Helft PR, Shahda S, Jalal SI, Champion VL.

Qual Life Res. 2018 Feb;27(2):515-528. doi: 10.1007/s11136-017-1620-7. Epub 2017 Jun 10.

PMID:
28601957
9.

A systematic review of psychosocial interventions for colorectal cancer patients.

Mosher CE, Winger JG, Given BA, Shahda S, Helft PR.

Support Care Cancer. 2017 Jul;25(7):2349-2362. doi: 10.1007/s00520-017-3693-9. Epub 2017 Apr 22. Review.

10.

A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.

Fogel EL, Shahda S, Sandrasegaran K, DeWitt J, Easler JJ, Agarwal DM, Eagleson M, Zyromski NJ, House MG, Ellsworth S, El Hajj I, O'Neil BH, Nakeeb A, Sherman S.

Am J Gastroenterol. 2017 Apr;112(4):537-554. doi: 10.1038/ajg.2016.610. Epub 2017 Jan 31. Review.

11.

Regulation of HIF1╬▒ under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.

Logsdon DP, Grimard M, Luo M, Shahda S, Jiang Y, Tong Y, Yu Z, Zyromski N, Schipani E, Carta F, Supuran CT, Korc M, Ivan M, Kelley MR, Fishel ML.

Mol Cancer Ther. 2016 Nov;15(11):2722-2732. Epub 2016 Aug 17.

12.

Positive changes among patients with advanced colorectal cancer and their family caregivers: a qualitative analysis.

Mosher CE, Adams RN, Helft PR, O'Neil BH, Shahda S, Rattray NA, Champion VL.

Psychol Health. 2017 Jan;32(1):94-109. Epub 2016 Oct 24.

13.

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.

Radovich M, Kiel PJ, Nance SM, Niland EE, Parsley ME, Ferguson ME, Jiang G, Ammakkanavar NR, Einhorn LH, Cheng L, Nassiri M, Davidson DD, Rushing DA, Loehrer PJ, Pili R, Hanna N, Callaghan JT, Skaar TC, Helft PR, Shahda S, O'Neil BH, Schneider BP.

Oncotarget. 2016 Aug 30;7(35):56491-56500. doi: 10.18632/oncotarget.10606.

14.

Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma.

Shahda S, Loehrer PJ, Clark RS, Spittler AJ, Althouse SK, Chiorean EG.

Oncologist. 2016 Jun;21(6):664-5. doi: 10.1634/theoncologist.2016-0071. Epub 2016 Jun 2.

15.

Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a History of Hairy Cell Leukemia.

Shah H, McPherson K, Mansour A, Ramirez-Santrich C, Nassiri M, Shahda S.

Clin Colorectal Cancer. 2016 Dec;15(4):e235-e239. doi: 10.1016/j.clcc.2016.03.006. Epub 2016 Mar 31. No abstract available.

PMID:
27117521
16.

Targeted therapy for advanced gastric cancer: A review of current status and future prospects.

Kanat O, O'Neil B, Shahda S.

World J Gastrointest Oncol. 2015 Dec 15;7(12):401-10. doi: 10.4251/wjgo.v7.i12.401. Review.

17.

Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives.

Mosher CE, Adams RN, Helft PR, O'Neil BH, Shahda S, Rattray NA, Champion VL.

Support Care Cancer. 2016 May;24(5):2017-2024. doi: 10.1007/s00520-015-2995-z. Epub 2015 Nov 4.

18.

Circulating tumor cell detection using a parallel flow micro-aperture chip system.

Chang CL, Huang W, Jalal SI, Chan BD, Mahmood A, Shahda S, O'Neil BH, Matei DE, Savran CA.

Lab Chip. 2015 Apr 7;15(7):1677-88. doi: 10.1039/c5lc00100e.

PMID:
25687986
19.

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.

Chiorean EG, Schneider BP, Akisik FM, Perkins SM, Anderson S, Johnson CS, DeWitt J, Helft P, Clark R, Johnston EL, Spittler AJ, Deluca J, Bu G, Shahda S, Loehrer PJ, Sandrasegaran K, Cardenes HR.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):284-91. doi: 10.1016/j.ijrobp.2014.02.024. Epub 2014 Apr 11.

PMID:
24726286
20.

GI-4000 in KRAS mutant cancers.

Shahda S, O'Neil B.

Expert Opin Investig Drugs. 2014 Feb;23(2):273-8. doi: 10.1517/13543784.2014.876408. Epub 2013 Dec 30. Review.

PMID:
24372276
21.

Regorafenib: from bench to bedside in colorectal cancer.

Shahda S, Saif MW.

Expert Rev Clin Pharmacol. 2013 May;6(3):243-8. doi: 10.1586/ecp.13.11.

PMID:
23656338
22.

APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.

Cardoso AA, Jiang Y, Luo M, Reed AM, Shahda S, He Y, Maitra A, Kelley MR, Fishel ML.

PLoS One. 2012;7(10):e47462. doi: 10.1371/journal.pone.0047462. Epub 2012 Oct 19.

23.

The human metapneumovirus: a case series and review of the literature.

Shahda S, Carlos WG, Kiel PJ, Khan BA, Hage CA.

Transpl Infect Dis. 2011 Jun;13(3):324-8. doi: 10.1111/j.1399-3062.2010.00575.x. Epub 2010 Oct 3. Review.

24.

Stents in the successful management of protein-losing enteropathy after fontan.

Shahda S, Zahra M, Fiore A, Jureidini S.

J Invasive Cardiol. 2007 Oct;19(10):444-6.

Supplemental Content

Loading ...
Support Center